Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

10.28USD
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
$10.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,630
52-wk High
$15.75
52-wk Low
$5.48

Select another date:

Fri, Jan 5 2018

BRIEF-Kalvista Pharmaceuticals Commences Two Clinical Trials

* KALVISTA PHARMACEUTICALS INC - TOP-LINE RESULTS ARE EXPECTED IN SECOND HALF OF 2019 FOR KVD001

BRIEF-Kalvista Pharmaceuticals Reports Q2 Loss Per Share $0.50

* KALVISTA PHARMACEUTICALS REPORTS FISCAL SECOND QUARTER RESULTS

BRIEF-Ra Capital Management says it purchased 850,000 shares of Kalvista Pharmaceuticals' common stock for about $7.2 mln

* Ra Capital Management says ‍​on Oct 12, it purchased 850,000 shares of Kalvista Pharmaceuticals' common stock for about $7.2 million - SEC Filing

BRIEF-Longwood Fund II reports 8.7 pct stake in Kalvista Pharmaceuticals ‍​

* Longwood Fund II Lp reports 8.7 pct stake in Kalvista Pharmaceuticals Inc as of Oct 12 - sec filing‍​ Source text - http://bit.ly/2xTHJJO Further company coverage:

BRIEF-Kalvista Pharmaceuticals announces collaboration with Merck

* Kalvista Pharmaceuticals announces collaboration with Merck

BRIEF-KalVista Pharmaceuticals reports Q1 loss per share of $0.51

* KalVista pharmaceuticals reports fiscal first quarter results

BRIEF-Kalvista Pharmaceuticals reports Q4 loss per share $0.43

* Kalvista Pharmaceuticals provides operational update and reports fiscal fourth quarter and full year financial results

Select another date: